CD4 and neoplasm: Administration of MEDI6469 resulted in an increase in the proliferation of tumour-infiltrating T cells, both CD4+ and CD8+, in tumour biopsies before and after surgery in patients with stage III and IV oral head and neck squamous cell carcinoma (OPC).